Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

3 Promising Treatments for a Surprisingly Common Health Problem
Motley Fool
Sunday, May 5, 2013 - 10:54am
tags:
MK-7243, allergic rhinitis, allergies, Ragweed Allergy, Merck, MK-3461, ALK-Abello
AVEO: Here's Looking At You, FDA
Seeking Alpha
Sunday, May 5, 2013 - 10:48am
tags:
Aveo Pharmaceuticals, tivozanib, renal cell carcinoma
2 Biotechs To Avoid, 1 To Buy
Motley Fool
Sunday, May 5, 2013 - 10:46am
tags:
Aveo Pharmaceuticals, InterMune, Galena Biopharma
It's Pipeline That Matters Most
The Street
Saturday, May 4, 2013 - 11:05am
tags:
Merck, Allergan, JNJ
Neurocrine Biosciences CEO Discuses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha
Saturday, May 4, 2013 - 11:03am
tags:
Neurocrine Biosciences, earnings
FDA approves J&J sedation drug device
Reuters
Saturday, May 4, 2013 - 11:02am
tags:
JNJ, Sedasys, propofol
Why Investors Shouldn't Worry About Sanofi's Poor Quarter
Motley Fool
Saturday, May 4, 2013 - 10:50am
tags:
Sanofi, earnings
J&J Recalls Some Children’s Tylenol in South Korea
Bloomberg
Saturday, May 4, 2013 - 10:49am
tags:
JNJ, Tylenol, recalls
Merck's Cholesterol Pill Win Is Already Drawing Fire Comment Now Follow Comments
Forbes
Saturday, May 4, 2013 - 10:48am
tags:
Liptruzet, Merck, cholesterol
FDA OKs Bristol's HIV drug for younger patients
Yahoo/AP
Saturday, May 4, 2013 - 10:46am
tags:
Bristol-Myers Squibb, Sustiva, HIV
Rigel Pharmaceuticals Becomes Oversold (RIGL)
The Street
Saturday, May 4, 2013 - 10:45am
tags:
Rigel Pharmaceuticals
Repligen's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha
Saturday, May 4, 2013 - 10:33am
tags:
Repligen, earnings
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Seeking Alpha
Saturday, May 4, 2013 - 10:32am
tags:
Vertex Pharmaceuticals, Pharmacyclics, Novartis, Celsion, Peregrine Pharmaceuticals, Prana, Navidea Biopharmaceuticals, Cardinal Health, ONYX Pharmaceuticals, Bayer, Sarepta, Hyperion Therapeutics, Amarin, Medivation, Astellas, JNJ, Trius, Sangamo BioSciences
Despite Poor Quarter, ViroPharma's Commercial And Pipeline Progress Continue
Seeking Alpha
Saturday, May 4, 2013 - 10:27am
tags:
ViroPharma
Regeneron Pharma raises sales forecast for Eylea
Yahoo/AP
Saturday, May 4, 2013 - 10:26am
tags:
Regeneron, Eylea, age-related macular degeneration, macular degeneration
Emergent BioSolutions' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha
Saturday, May 4, 2013 - 10:25am
tags:
Emergent BioSolutions, earnings
Vertex Pharmaceuticals: Today's Featured Drugs Laggard
The Street
Saturday, May 4, 2013 - 10:24am
tags:
Vertex Pharmaceuticals
Onyx Pharmaceuticals Inc.: Today's Featured Health Care Laggard
The Street
Saturday, May 4, 2013 - 10:23am
tags:
ONYX Pharmaceuticals
China's H7N9 Bird Flu And Novavax
Seeking Alpha
Saturday, May 4, 2013 - 10:22am
tags:
H7N9, Novavax, vaccines, flu vaccines
Why Exact Sciences Is Poised to Underperform
Motley Fool
Saturday, May 4, 2013 - 10:20am
tags:
EXACT Sciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.